Therapeutic Solutions International (OTCMKTS:TSOI) Appoints Dr. Donald Banerji to Scientific Advisory Board

The appointment of accomplished individuals to the scientific advisory boards of pharmaceutical companies can often come as a major positive trigger for the stocks and that is what happened with the Therapeutic Solutions International (OTCMKTS:TSOI) stock on Wednesday.

Trading Data

On Wednesday, TSOI stock increased 3.77% to $0.0220 with more than 2.38 million shares, compared to its average volume of 4.71 million shares. The stock moved within a range of $0.0208 – 0.0227 after opening trade at $0.0227.

The stock came into considerable focus after it announced that it had appointed Dr. Donald Banerji to its scientific advisory board. It came as a source of considerable optimism for investors and the stock soon climbed by as much as 4% for the day. It is going to be very interesting to see if the Therapeutic Solutions International stock can manage to hold on to its momentum and add to its gains today.

It ought to be noted that the scientific advisory board at the company is already populated with highly accomplished individuals and Banerji is the latest addition to it. Timothy Dixon, who is the President and Chief Executive Officer of Therapeutic Solutions International, noted that the addition of Dr Banerji was timed perfectly since the company was conducting the Phase 3 clinical trial on patients suffering from COVID 19 infection. It may be a good time for investors to add the Therapeutic Solutions International stock to their watch lists.

Key Quote

“I am pleased to welcome Dr. Banerji to our Scientific Advisory Board. His addition is perfectly timed as the Company is conducting a Phase III clinical trial in advanced COVID-19 patients1 and has recently filed an Investigational New Drug Application (IND) for treatment of Chronic Obstructive Pulmonary Disease (COPD)2,” said Timothy Dixon, President and Chief Executive Officer of the Company.

Technical Data

TSOI stock is trading below the 20-Day and 50-Day Moving averages of $0.0239 and $0.0246 respectively. Moreover, the stock is trading below the 200-Day moving average of $0.0374.